InVision Precision Cardiac Amyloid vs cV5 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

InVision Precision Cardiac Amyloid

by InVision Medical Technology

cV5 Diagnostic Ultrasound System

by Samsung Medison

AI Verdict

Tool A is a specialized AI software designed for the precise detection of cardiac amyloidosis from existing echocardiogram studies. In contrast, Tool B is a comprehensive, AI-assisted diagnostic ultrasound hardware system offering versatile imaging capabilities across multiple specialties, including cardiology. While both leverage AI in cardiology, Tool A focuses on a specific diagnostic challenge, whereas Tool B provides a broad imaging platform.

Choose InVision Precision Cardiac Amyloid if…

Choose InVision Precision Cardiac Amyloid if your primary need is highly specialized, AI-driven detection of cardiac amyloidosis from existing echocardiogram studies. This software is ideal for cardiology practices and labs seeking to enhance diagnostic precision and reduce misdiagnosis specifically for this life-threatening condition, integrating seamlessly into current echocardiography workflows.

View InVision Precision Cardiac Amyloid →

Choose cV5 Diagnostic Ultrasound System if…

Choose the Samsung cV5 Diagnostic Ultrasound System if you require a comprehensive, versatile ultrasound hardware solution for a broad spectrum of diagnostic imaging across multiple specialties like cardiology, OB/GYN, and radiology. This system offers advanced AI-assisted imaging and productivity tools for general diagnostic confidence, making it suitable for facilities needing a robust, all-in-one ultrasound platform.

View cV5 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	InVision Precision Cardiac Amyloid	cV5 Diagnostic Ultrasound System
Deployment	Cloud or on-premise	On-premise (ultrasound system)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cV5 Diagnostic Ultrasound System

Tool B, as a complete ultrasound system, explicitly highlights ergonomic design, a tilting touchscreen, and specific AI-powered productivity tools like EzExam+ and QuickScan, indicating a strong focus on enhancing the direct user experience and streamlining workflows. While Tool A integrates into existing workflows, Tool B provides more detailed features directly related to ease of use and operator comfort.

Clinical Value

InVision Precision Cardiac Amyloid

Tool A offers highly specialized clinical value by focusing on the earlier detection and reduction of misdiagnosis for cardiac amyloidosis, a life-threatening condition, backed by an evidence-based AI algorithm published in JAMA Cardiology. While Tool B provides broad diagnostic capabilities and enhanced imaging, Tool A's targeted approach to a critical, often-missed disease with strong validation demonstrates superior specific clinical impact.

Pricing & Value

InVision Precision Cardiac Amyloid

Tool A provides transparent pricing with a clear starting subscription cost of $49/month, which allows potential users to quickly assess affordability. In contrast, Tool B requires direct vendor contact for pricing information, offering less immediate transparency for budgeting and evaluation.

Enterprise Readiness

cV5 Diagnostic Ultrasound System

Tool B demonstrates stronger enterprise readiness through its explicit mention of a comprehensive Cybersecurity Suite with DICOM TLS and HL7 integration, extensive onboard storage, and broad data export capabilities. These features are critical for secure data handling, interoperability, and robust operation within complex hospital IT infrastructures, surpassing the general HIPAA compliance and enterprise pricing mentioned by Tool A.

Innovation

cV5 Diagnostic Ultrasound System

Tool B exhibits broader innovation through its advanced imaging technologies like Crystal Architecture and a wide array of AI & Productivity Tools applicable across multiple medical specialties. While Tool A's AI for cardiac amyloidosis is a significant innovation in a specific domain, Tool B's comprehensive suite of cutting-edge features demonstrates a wider scope of technological advancement.

Support & Docs

Tie

The provided structured facts for both Tool A and Tool B do not contain specific information regarding their support services or documentation availability. Without further verifiable details, it is not possible to distinguish between the two products on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	InVision Precision Cardiac Amyloid	cV5 Diagnostic Ultrasound System
Tool Name	InVision Precision Cardiac Amyloid	cV5 Diagnostic Ultrasound System
Company	InVision Medical Technology Corporation	Samsung Medison Co.
Primary Purpose	AI-powered software for echocardiography to detect cardiac amyloidosis, aiming for earlier detection and improved patient outcomes.	Versatile, AI-assisted ultrasound solution offering high-quality imaging, streamlined workflows, and ergonomic design for confident decision-making across various medical specialties.
Target Specialties	Cardiology, Radiology	Cardiology, Obstetrics & Gynecology, Radiology
Core AI Focus	AI-powered detection of cardiac amyloidosis (AL and ATTR types) from transthoracic echocardiogram studies.	AI & Productivity Tools including HeartAssistu2122, AutoEF, Strain+, TMAD, AutoIMT+, ArterialAnalysisu2122, EzExam+, EzCompareu2122, EzPrepu2122, SonoSyncu2122, QuickScanu2122, BiometryAssistu2122.
Key Imaging/Workflow Features	Evaluation of apical-4-chamber and parasternal-long-axis view videos, precise assessment of wall thickness, evidence-based AI algorithm.	Crystal Architectureu2122 for enhanced image quality, broad compatibility with S-Vueu2122 transducers, multiple imaging modes (2D, M-Mode, Color/Power Doppler, 3D/4D), 512GB SSD + 1TB expanded storage, Cybersecurity Suite with DICOM TLS and HL7 integration.

Videos

Demos, reviews, and walkthroughs featuring InVision Precision Cardiac Amyloid and cV5 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the type of solution offered by each tool?

InVision Precision Cardiac Amyloid (Tool A) is an AI-powered software as a Medical Device (SaMD) specifically designed for detecting cardiac amyloidosis using echocardiography. The Samsung cV5 Diagnostic Ultrasound System (Tool B) is an on-premise hardware ultrasound system that offers versatile, AI-assisted imaging across various medical specialties.

How do the AI capabilities of these tools differ in their application?

Tool A's AI is highly specialized for the detection of AL and ATTR Cardiac Amyloidosis, evaluating transthoracic echocardiogram studies. Tool B provides a broader suite of AI & Productivity Tools, such as HeartAssist, AutoEF, and Strain+, to enhance general diagnostic confidence and streamline workflows across multiple applications, including cardiology.

What evidence supports the clinical utility of each tool?

InVision Precision Cardiac Amyloid (Tool A) features an evidence-based AI algorithm that has been peer-reviewed and published in JAMA Cardiology, and it has received FDA 510(k) clearance and Breakthrough Device Designation. The Samsung cV5 Diagnostic Ultrasound System (Tool B) emphasizes high-quality imaging through its Crystal Architecture and a range of AI-assisted tools designed to improve diagnostic accuracy and workflow efficiency.

How do the pricing and data handling compliance models compare?

InVision Precision Cardiac Amyloid (Tool A) is available on a subscription basis starting at $49/month and is HIPAA compliant. The Samsung cV5 Diagnostic Ultrasound System (Tool B) requires contacting the vendor for pricing information and is HIPAA compliant when used in a HIPAA-compliant environment with appropriate data handling practices, with a BAA requiring vendor contact.

Which medical specialties are supported by each tool?

InVision Precision Cardiac Amyloid (Tool A) is designed for Cardiology and Radiology, specifically focusing on cardiac amyloidosis detection. The Samsung cV5 Diagnostic Ultrasound System (Tool B) is a versatile solution supporting Cardiology, Obstetrics & Gynecology, and Radiology, with broad compatibility for diverse applications.